Robert A MacLeod

USPTO Granted Patents = 18 (Patent Applications = 10)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 105(Granted Patents)

Location History:

Carlsbad, CA (US) (2015 - 2021)
San Diego, CA (US) (2014 - 2024)

Company Filing History:

12 out of 270

Ionis Pharmaceuticals, Inc.

patents

5 out of 1,035

Isis Pharmaceuticals, Inc.

patents

1 out of 5

Lonis Pharmaceuticals, Inc.

patents

Years Active: 2014-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12042510 - Modulators of IRF4 expression (2024-07-23),

2. 11547718 - Modulators of FOXP3 expression (2023-01-10),

3. 11365416 - Modulators of EZH2 expression (2022-06-21),

4. 11279932 - Modulators of MALAT1 expression (2022-03-22),

5. 11241451 - Modulators of IRF4 expression (2022-02-08),

6. 11214803 - Modulators of YAP1 expression (2022-01-04),

7. RE48461 - Modulation of androgen receptor expression (2021-03-08),

8. 10479993 - Modulation of signal transducer and activator of transcription 3 (STAT3) expression (2019-11-19),

9. 9765338 - Modulation of dystrophia myotonica-protein kinase (DMPK) expression (2017-09-19),

10. 9567588 - Modulation of androgen receptor expression (2017-02-14),

11. 9546368 - Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression (2017-01-17),

12. 9359608 - Modulation of signal transducer and activator of transcription 3 (STAT3) expression (2016-06-07),

13. 9322021 - Methods for modulating kallikrein (KLKB1) expression (2016-04-26),

14. 9315811 - Methods for modulating kallikrein (KLKB1) expression (2016-04-19),

15. 9187749 - Methods for modulating factor 12 expression (2015-11-17),

Title: The Innovative Contributions of Robert A. MacLeod

Introduction

Robert A. MacLeod is a prominent inventor based in Carlsbad, California, known for his significant contributions to the field of biotechnology. With a total of 18 patents to his name, MacLeod has made remarkable advancements in cancer treatment through his innovative research.

Latest Patents

Among his latest patents are "Modulators of IRF4 expression" and "Modulators of FOXP3 expression." The former provides methods, compounds, and compositions useful for inhibiting IRF4 expression, which may be beneficial for treating, preventing, or ameliorating cancers associated with IRF4. The latter focuses on inhibiting FOXP3 expression, offering potential treatments for various cancers.

Career Highlights

MacLeod has had a distinguished career, working with notable companies such as Ionis Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. His work in these organizations has contributed to the development of groundbreaking therapies aimed at combating cancer.

Collaborations

Some of his notable coworkers include Susan M. Freier and Youngsoo Kim, who have collaborated with him on various projects, enhancing the impact of his research.

Conclusion

Robert A. MacLeod's innovative work and dedication to cancer research have established him as a key figure in biotechnology. His patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.